DNA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Ginkgo Bioworks Holdings Inc (DNA).


$3.58B Market Cap.

As of 03/01/2024 5:00 PM ET (MRY) • Disclaimer

DNA Market Cap. (MRY)


DNA Shares Outstanding (MRY)


DNA Assets (MRY)


Total Assets

$1.67B

Total Liabilities

$568.19M

Total Investments

$78.56M

DNA Income (MRY)


Revenue

$251.46M

Net Income

-$892.87M

Operating Expense

$1.06B

DNA Cash Flow (MRY)


CF Operations

-$295.50M

CF Investing

-$80.69M

CF Financing

-$3.22M

DNA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

0%

0%

-

2019

$0

-

-

0%

-

DNA Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$1,665,342,000 (-34.42%)

$2,539,321,000 (22.61%)

$2,070,990,000 (206.74%)

$675,153,000 (-3.18%)

Assets Current

$1,001,749,000 (-30.92%)

$1,450,079,000 (-15.84%)

$1,723,045,000 (303.96%)

$426,542,000 (-16.68%)

Assets Non-Current

$663,593,000 (-39.08%)

$1,089,242,000 (213.05%)

$347,945,000 (39.96%)

$248,611,000 (34.10%)

Goodwill & Intangible Assets

$131,979,000 (-22.93%)

$171,251,000 (298.68%)

$42,954,000 (733.90%)

$5,151,000 (-9.63%)

Shareholders Equity

$1,097,152,000 (-36.81%)

$1,736,277,000 (15.34%)

$1,505,365,000 (226.28%)

$461,376,000 (-6.43%)

Property Plant & Equipment Net

$394,994,000 (-44.80%)

$715,535,000 (390.87%)

$145,770,000 (20.04%)

$121,435,000 (92.35%)

Cash & Equivalents

$944,073,000 (-28.25%)

$1,315,792,000 (-15.11%)

$1,550,004,000 (307.04%)

$380,801,000 (-23.12%)

Accumulated Other Comprehensive Income

$1,484,000 (156.38%)

-$2,632,000 (-53.47%)

-$1,715,000 (0%)

$0 (0%)

Deferred Revenue

$202,548,000 (-9.00%)

$222,584,000 (17.63%)

$189,231,000 (47.29%)

$128,475,000 (-13.13%)

Total Investments

$78,565,000 (-30.92%)

$113,731,000 (-1.30%)

$115,231,000 (-1.02%)

$116,422,000 (4.91%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$78,565,000 (-30.92%)

$113,731,000 (-1.30%)

$115,231,000 (-1.02%)

$116,422,000 (4.91%)

Inventory

$0 (0%)

$4,364,000 (29.80%)

$3,362,000 (22.88%)

$2,736,000 (0%)

Trade & Non-Trade Receivables

$17,899,000 (-78.30%)

$82,465,000 (-39.43%)

$136,142,000 (521.48%)

$21,906,000 (185.31%)

Trade & Non-Trade Payables

$9,323,000 (-10.79%)

$10,451,000 (27.62%)

$8,189,000 (-41.06%)

$13,893,000 (469.62%)

Accumulated Retained Earnings (Deficit)

-$5,290,528,000 (-20.30%)

-$4,397,659,000 (-91.38%)

-$2,297,925,000 (-391.14%)

-$467,878,000 (-37.10%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$221,835,000 (-46.32%)

$413,256,000 (1754.58%)

$22,283,000 (34.90%)

$16,518,000 (-1.49%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$221,835,000 (-46.32%)

$413,256,000 (1754.58%)

$22,283,000 (34.90%)

$16,518,000 (-1.49%)

Total Liabilities

$568,190,000 (-29.25%)

$803,044,000 (59.46%)

$503,611,000 (145.54%)

$205,101,000 (4.93%)

Liabilities Current

$163,860,000 (-5.26%)

$172,962,000 (28.35%)

$134,761,000 (84.05%)

$73,221,000 (82.71%)

Liabilities Non-Current

$404,330,000 (-35.83%)

$630,082,000 (70.82%)

$368,850,000 (179.69%)

$131,880,000 (-15.13%)

DNA Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$251,455,000 (-47.36%)

$477,706,000 (52.21%)

$313,837,000 (309.40%)

$76,657,000 (41.48%)

Cost of Revenue

$54,005,000 (-73.55%)

$204,216,000 (57.46%)

$129,690,000 (730.76%)

$15,611,000 (0%)

Selling General & Administrative Expense

$385,025,000 (-73.07%)

$1,429,799,000 (65.69%)

$862,952,000 (2152.79%)

$38,306,000 (29.93%)

Research & Development Expense

$580,621,000 (-44.84%)

$1,052,643,000 (-8.44%)

$1,149,662,000 (619.59%)

$159,767,000 (65.91%)

Operating Expenses

$1,061,856,000 (-57.23%)

$2,482,442,000 (23.34%)

$2,012,614,000 (916.10%)

$198,073,000 (57.47%)

Interest Expense

$93,000 (-12.26%)

$106,000 (-95.53%)

$2,373,000 (-0.50%)

$2,385,000 (-1.49%)

Income Tax Expense

-$71,000 (99.53%)

-$15,027,000 (-915.34%)

-$1,480,000 (-178.35%)

$1,889,000 (8486.36%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$892,869,000 (57.61%)

-$2,106,372,000 (-14.69%)

-$1,836,642,000 (-1349.34%)

-$126,723,000 (-5.73%)

Net Income to Non-Controlling Interests

$0 (0%)

-$1,443,000 (78.12%)

-$6,595,000 (-5685.09%)

-$114,000 (78.49%)

Net Income

-$892,869,000 (57.58%)

-$2,104,929,000 (-15.02%)

-$1,830,047,000 (-1345.43%)

-$126,609,000 (-6.10%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$892,869,000 (57.58%)

-$2,104,929,000 (-15.02%)

-$1,830,047,000 (-1345.43%)

-$126,609,000 (-6.10%)

Weighted Average Shares

$1,944,420,000 (15.80%)

$1,679,061,465 (23.47%)

$1,359,848,803 (6.67%)

$1,274,766,915 (10.95%)

Weighted Average Shares Diluted

$1,944,420,000 (15.75%)

$1,679,838,849 (23.48%)

$1,360,373,343 (6.72%)

$1,274,766,915 (10.95%)

Earning Before Interest & Taxes (EBIT)

-$892,847,000 (57.88%)

-$2,119,850,000 (-15.89%)

-$1,829,154,000 (-1395.20%)

-$122,335,000 (-4.66%)

Gross Profit

$197,450,000 (-27.80%)

$273,490,000 (48.52%)

$184,147,000 (201.65%)

$61,046,000 (12.66%)

Operating Income

-$864,406,000 (60.87%)

-$2,208,952,000 (-20.81%)

-$1,828,467,000 (-1234.38%)

-$137,027,000 (-91.38%)

DNA Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$80,693,000 (-19.73%)

-$67,394,000 (8.00%)

-$73,257,000 (-9.14%)

-$67,121,000 (10.03%)

Net Cash Flow from Financing

-$3,216,000 (-103.37%)

$95,337,000 (-93.79%)

$1,534,145,000 (1598.60%)

$90,318,000 (-77.99%)

Net Cash Flow from Operations

-$295,500,000 (-17.17%)

-$252,198,000 (0.64%)

-$253,818,000 (-86.86%)

-$135,830,000 (-204.12%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$379,997,000 (-70.14%)

-$223,347,000 (-118.50%)

$1,207,051,000 (1171.67%)

-$112,633,000 (-138.69%)

Net Cash Flow - Business Acquisitions and Disposals

-$43,330,000 (-106.40%)

-$20,993,000 (-74.36%)

-$12,040,000 (-19.21%)

-$10,100,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$6,309,000 (234.35%)

-$4,696,000 (-687.00%)

$800,000 (101.53%)

Capital Expenditure

-$36,373,000 (30.41%)

-$52,271,000 (7.52%)

-$56,521,000 (2.25%)

-$57,821,000 (-160.23%)

Issuance (Repayment) of Debt Securities

-$1,295,000 (-4.69%)

-$1,237,000 (-10.15%)

-$1,123,000 (-50.13%)

-$748,000 (-100.38%)

Issuance (Purchase) of Equity Shares

-$487,000 (-100.50%)

$98,076,000 (-93.39%)

$1,484,798,000 (5710661.54%)

$26,000 (106.48%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$588,000 (-164.76%)

$908,000 (4878.95%)

-$19,000 (0%)

$0 (0%)

Share Based Compensation

$229,884,000 (-88.09%)

$1,930,641,000 (20.21%)

$1,606,020,000 (337299.16%)

$476,000 (-38.26%)

Depreciation Amortization & Accretion

$99,867,000 (57.26%)

$63,505,000 (118.41%)

$29,076,000 (109.72%)

$13,864,000 (28.91%)

DNA Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

78.50% (37.00%)

57.30% (-2.39%)

58.70% (-26.26%)

79.60% (-20.40%)

Profit Margin

-355.10% (19.41%)

-440.60% (24.44%)

-583.10% (-252.97%)

-165.20% (24.98%)

EBITDA Margin

-315.40% (26.74%)

-430.50% (24.95%)

-573.60% (-305.37%)

-141.50% (27.77%)

Return on Average Equity (ROAE)

-65.40% (51.16%)

-133.90% (30.59%)

-192.90% (-627.92%)

-26.50%

Return on Average Assets (ROAA)

-42.50% (57.29%)

-99.50% (25.91%)

-134.30% (-629.89%)

-18.40%

Return on Sales (ROS)

-355.10% (19.99%)

-443.80% (23.85%)

-582.80% (-265.16%)

-159.60% (26.01%)

Return on Invested Capital (ROIC)

-84.50% (74.36%)

-329.50% (46.27%)

-613.20% (-916.92%)

-60.30%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-3.67 (-171.75%)

-1.35 (78.04%)

-6.16

-

Price to Sales Ratio (P/S)

13.07 (120.00%)

5.94 (-83.50%)

36.01

-

Price to Book Ratio (P/B)

3.26 (72.83%)

1.89 (-77.00%)

8.21

-

Debt to Equity Ratio (D/E)

0.52 (11.88%)

0.46 (38.21%)

0.34 (-24.72%)

0.45 (12.37%)

Earnings Per Share (EPS)

-0.46 (63.20%)

-1.25 (7.41%)

-1.35 (-1250.00%)

-0.1 (0.00%)

Sales Per Share (SPS)

0.13 (-54.74%)

0.28 (23.38%)

0.23 (285.00%)

0.06 (27.66%)

Free Cash Flow Per Share (FCFPS)

-0.17 (5.52%)

-0.18 (20.61%)

-0.23 (-50.00%)

-0.15 (-162.07%)

Book Value Per Share (BVPS)

0.56 (-45.45%)

1.03 (-6.59%)

1.11 (205.80%)

0.36 (-15.62%)

Tangible Assets Book Value Per Share (TABVPS)

0.79 (-44.04%)

1.41 (-5.43%)

1.49 (183.46%)

0.53 (-12.62%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (-200.00%)

-1 (83.33%)

-6

-

Enterprise Value Over EBITDA (EV/EBITDA)

-3.7 (-273.84%)

-0.99 (83.24%)

-5.91

-

Asset Turnover

0.12 (-46.90%)

0.23 (-1.74%)

0.23 (105.36%)

0.11

Current Ratio

6.11 (-27.09%)

8.38 (-34.43%)

12.79 (119.50%)

5.83 (-54.40%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$331,873,000 (-9.00%)

-$304,469,000 (1.89%)

-$310,339,000 (-60.26%)

-$193,651,000 (-189.54%)

Enterprise Value (EV)

$2,934,575,780 (44.15%)

$2,035,804,972 (-80.85%)

$10,631,973,817

-

Earnings Before Tax (EBT)

-$892,940,000 (57.88%)

-$2,119,956,000 (-15.75%)

-$1,831,527,000 (-1368.51%)

-$124,720,000 (-4.54%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$792,980,000 (61.44%)

-$2,056,345,000 (-14.24%)

-$1,800,078,000 (-1559.50%)

-$108,471,000 (-2.21%)

Invested Capital

$647,265,000 (-49.92%)

$1,292,572,000 (253.59%)

$365,554,000 (57.23%)

$232,498,000 (34.37%)

Working Capital

$837,889,000 (-34.39%)

$1,277,117,000 (-19.59%)

$1,588,284,000 (349.53%)

$353,321,000 (-25.12%)

Tangible Asset Value

$1,533,363,000 (-35.25%)

$2,368,070,000 (16.77%)

$2,028,036,000 (202.69%)

$670,002,000 (-3.13%)

Market Capitalization

$3,580,157,780 (9.20%)

$3,278,565,972 (-73.46%)

$12,354,761,817

-

Average Equity

$1,365,251,500 (-13.14%)

$1,571,809,750 (65.72%)

$948,465,000 (98.75%)

$477,219,500

Average Assets

$2,100,235,500 (-0.72%)

$2,115,490,250 (55.20%)

$1,363,031,250 (98.62%)

$686,235,500

Invested Capital Average

$1,056,850,250 (64.28%)

$643,332,750 (115.68%)

$298,287,750 (47.11%)

$202,761,000

Shares

2,118,436,556 (9.20%)

1,939,979,865 (30.49%)

1,486,734,274 (589.50%)

215,625,000